Ketograce DS Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a nutritional supplement in the management of chronic kidney disease (CKD). This formulation provides essential ketoanalogues of amino acids, which are precursors that the body can convert into amino acids, thereby reducing the nitrogenous waste burden on the kidneys. Ketograce DS is indicated for patients with CKD stages 3 to 5, particularly those on a low-protein diet, to help maintain nutritional status while minimizing the accumulation of toxic metabolites. By supplementing with Alpha Ketoanalogue, the tablet aids in preventing protein malnutrition and supports metabolic balance without increasing nitrogenous waste. The use of Ketograce DS is often integrated into a comprehensive treatment plan that includes dietary protein restriction and regular monitoring of renal function. It is essential to administer this medication under medical supervision, as dosage adjustments may be necessary based on the patient’s renal status and nutritional requirements. Adverse effects are uncommon but may include gastrointestinal discomfort. Ketograce DS Tablet should be stored in a cool, dry place and kept out of reach of children. It is contraindicated in patients with hypersensitivity to any component of the formulation.